Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Johnson & Johnson Private Limited

Clinical trials sponsored by Johnson & Johnson Private Limited, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Indian subsidiary of the global healthcare giant Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New drug teclistamab tested for safety in Tough-to-Treat blood cancer

Disease control Ongoing

This study tests the safety of teclistamab, a drug given as a shot, in 75 Indian adults with multiple myeloma that has come back or not responded to at least three prior treatments. The goal is to see how safe it is in routine practice. Participants must have tried specific prior…

Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC